Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Wave Life Sciences (WVE) EPS (Basic) (2016 - 2025)

Wave Life Sciences' EPS (Basic) history spans 11 years, with the latest figure at -$0.29 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 207.41% year-over-year to -$0.29; the TTM value through Dec 2025 reached -$1.21, down 75.36%, while the annual FY2025 figure was -$1.21, 72.86% down from the prior year.
  • EPS (Basic) reached -$0.29 in Q4 2025 per WVE's latest filing, up from -$0.32 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.27 in Q4 2024 to a low of -$0.86 in Q1 2021.
  • Average EPS (Basic) over 5 years is -$0.35, with a median of -$0.3 recorded in 2025.
  • The largest YoY upside for EPS (Basic) was 280.0% in 2024 against a maximum downside of 771.43% in 2024.
  • A 5-year view of EPS (Basic) shows it stood at -$0.61 in 2021, then rose by 26.23% to -$0.45 in 2022, then soared by 66.67% to -$0.15 in 2023, then skyrocketed by 280.0% to $0.27 in 2024, then tumbled by 207.41% to -$0.29 in 2025.
  • Per Business Quant, the three most recent readings for WVE's EPS (Basic) are -$0.29 (Q4 2025), -$0.32 (Q3 2025), and -$0.31 (Q2 2025).